Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Drug Name Guidance Will Address Labeling and Packaging-Related Errors

Apr 02 2001

• By The Pink Sheet

Related Content

Pfizer Ziprasidone Labeling Stops Short Of Second-Line Use; QT Effect Noted

Feb 12 2001

Novartis Zelmac Trade Name Could Be Changed Following FDA Discussions

Feb 19 2001

Indication, Warning Summaries In Labeling "Highlights" - FDA Rule

Jan 01 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window